dihexa potency compared to bdnf human clinical trial trials status Dihexa shows neurotrophic activity exceeding in preclinical studies DIHEXA | Peptide Synthetic Evaluation of Metabolically Stabilized Angiotensin

Die Studien dokumentieren eine signifikante Reduktion der Entzndungsmarker, eine beschleunigte Regeneration der Darmschleimhaut und eine Verbesserung der histologischen Befunde

Dihexa should not replace conventional medical treatment for serious neurological conditions or cognitive disorders

(Presented/Published in JSCR Supplement) Ann Dunn, Farrell III, J.W., Lantis, D.J., Barton, M.A., Shipman, S.R., Cantrell, G.S., Campbell, J.A., Bemben, M.G., Larson, D.J., & Larson, R.D

The arginate salt form of BPC-157 demonstrates dramatically different oral pharmacokinetics compared to the acetate form

at 1-877-845-0689, or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch